05/15/2025
11:15 PM | Werewolf Therapeutics (Filer)
| Form EFFECT | |
05/14/2025
5:08 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
5:09 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Werewolf Therapeutics (Subject)
| Form SCHEDULE 13D/A | |
05/08/2025
6:06 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:10 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2025
4:38 PM | Bloom Steven H. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/30/2025
3:17 PM | Foley Todd (Reporting)
MPM Asset Management Investors BV2014 LLC (Reporting)
MPM BioVentures 2014 , L.P. (0001609493) (Reporting)
MPM BioVentures 2014 GP LLC (Reporting)
MPM BioVentures 2014 LLC (Reporting)
MPM BioVentures 2014, L.P. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2025
6:58 AM | Werewolf Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025
6:58 AM | Werewolf Therapeutics (Filer)
| Form DEFA14A | |
04/28/2025
7:13 AM | Werewolf Therapeutics (Filer)
| Form ARS | |
03/11/2025
6:33 AM | Werewolf Therapeutics (Filer)
| Form 424B5 | |
Get the Latest News and Ratings for HOWL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Werewolf Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/11/2025
6:20 AM | Werewolf Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2025
6:05 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
6:10 AM | Werewolf Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
6:49 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2025
4:54 PM | Singhal Anil K. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/21/2025
4:57 PM | Singhal Anil K. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:43 PM | Karunatilake Chulani (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:44 PM | Isaacs Randi (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:44 PM | Trost Timothy W. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:51 PM | Lubman Ellen (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
4:41 PM | HICKLIN DANIEL J (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:04 PM | PFM Health Sciences, LP (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024
10:54 AM | BANK OF AMERICA CORP /DE/ (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Rubric Capital Management LP (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
8:37 AM | Adage Capital Management, L.P. (Filed by)
Werewolf Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024
8:06 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
8:09 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:21 AM | Werewolf Therapeutics (Filer)
| Form S-8 POS | |
08/08/2024
6:07 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:12 AM | Werewolf Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/25/2024
6:07 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
6:56 AM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:27 PM | Werewolf Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
6:44 PM | Lazarus Alon (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:45 PM | EVNIN LUKE (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:45 PM | Sherman Michael A. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:46 PM | Chatterjee Meeta (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:48 PM | Atkins Michael B. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:49 PM | Morrison Briggs (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
6:52 PM | DiRocco Derek (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Here’s your answer (Ad) Porter Stansberry is stepping into the spotlight — and putting real skin in the game.
For the first time ever, he’s opening the doors to a live, real-money trading account, managed transparently with the same strategies he’s used to build long-term wealth. Every 90 days, he and his lead analyst release a new tranche of trades designed for serious investors who don’t want to babysit the market. The goal: income, downside protection, and asymmetric upside. Lance James breaks down the full FAQ on what this is (and isn’t) — including why they believe now i |
05/24/2024
6:56 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Werewolf Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy HOWL Stock Free HOWL Stock Alerts